583
Views
4
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

The cumulative incidence of gemcitabine-induced thrombotic microangiopathy

, &
Pages 545-546 | Received 01 Aug 2006, Published online: 08 Jul 2009

References

  • Murgo AJ. Cancer- and chemotherapy-associated thrombotic microangiopathy. Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura, BS Kaplan, RS Trompeter, JL Moake. Marcel Dekker, New York 1992; 271–85
  • Fung MC, Storniolo AM, Nguyen B, Arning M, Brookfield W, et al. Review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer 1999; 85: 2023–32
  • Humphreys BD, Sharman JP, Henderson JM, Clark JW, Marks PW, et al. Gemcitabine-associated thrombotic microangiopathy. Cancer 2004; 100: 2664–70
  • Müller S, Schütt P, Bojko P, Nowrousian MR, Hense J, et al. Hemolytic uremic syndrome following prolonged gemcitabine therapy: Report of four cases from a single institution. Ann Hematol 2005; 84: 110–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.